Articles On Cardiex (ASX:CDX)

It’s been a big few weeks for CardieX (ASX:CDX) as the health technology company restructured itself into two divisions, worked to protect its intellectual property and announced a new strategic partnership. CardieX has five new products in...

Summary Little Green Pharma (ASX:LGP) boosts growth strategy, acquires production facility in Denmark Talga (ASX:TLG) signs supply deal with Nordic Battery maker FREYR Peppermint Innovation (ASX:PIL) closes strong on partnership with...

Summary The ASX 200 closed 1.48% higher at 7,342.20, recouping previous session losses. Ten of the 11 sectors ended in green, while the energy sector emerged as the top performer with 2.35% gain. Minding firm Pilbara Minerals was the...

Plenty of action on the biotech front today has provided ASX investors with some mouth-watering gains. Suda Pharma (ASX:SUD) led the pack, popping by as much as 44 per cent after announcing an oversubscribed $3.65 million capital raise. The...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Summary The benchmark index was up today, with most of the indices trading in the green zone. archTIS has secured a contract with an Australian national security agency to procure extra NC Protect software licences. Xref Limited repor...

Australian medtech CardieX has announced the launch of CONNEQT; a new consumer health division to focus on wearables and home health devices. CardieX (ASX: CDX), the Australian medical technology company, has announced that its subsidiary A...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Summary Health technology player CardieX Limited reported an impressive 29% growth in its sales during Q2 FY2021. XCEL and Oscar 2 devices reported robust sales numbers despite the COVID-19 pandemic. The Company is expected to launch...

The Cardiex Ltd (ASX: CDX) share price is up 3.9% to 5.3 cents in afternoon trading after the company released a positive update on its half year sales. The rise comes as the wider All Ordinaries Index (ASX: XAO) is slipping, down 0.2% to...

The Cardiex Ltd (ASX: CDX) share price was rising today as the company announced it had received a new blood pressure patent. The Cardiex share price closed today’s trading 6.12% higher at 5.2 cents. What Cardiex does Cardiex is a global h...

A quick wrap of the ASX’s key winners and losers on Wednesday, September 16. Data is taken after the market closes at 4pm AEST. Stocks highlighted in yellow made potentially market-moving announcements during the day. WINNERS TICKE...

Special Report: CardieX has inked one of its most significant deals to date, securing a partnership with one of China’s largest electronic medical device manufacturers and opening the doors to a US$509 billion market opportunity. CardieX (A...

Seasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the radio booth for another instalment of The StockDoc Podcast. This week, the good doctor sits down with Craig Cooper, CEO & managing direc...

Medical technology company CardieX (ASX:CDX) says it has successfully completed a $2.5 million placement offered to sophisticated investors at $0.03 per share with a one-for-five free attaching listed option.

Digital health technology company CardieX (ASX: CDX) has announced its wearables co-development partner Blumio Inc has secured an agreement with Germany’s Infineon Technologies for the commercialisation of blood pressure sensor technology b...

Research house MST Access initiated coverage on Cardiex in September 2019 with an 8.2 cents per share valuation using discounted cash flow methodology (current price: 2.4 cents).

Research house MST Access initiated coverage on Cardiex in September 2019 with an 8.2 cents per share valuation using discounted cash flow methodology (current price: 2.4 cents).

A wholly-owned subsidiary of CardieX (ASX: CDX) has become the world’s first company to develop a medically-reliable photoplethysmography (PPG) sensor product for smartwatches and other wearable devices. Medical technology firm Atcor has be...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

CardieX’s (CDX) subsidiary, ATCOR, has won a contract with Bayer AG to provide clinical trial services ATCOR will utilise its XCELL and Oscar 2 technology and data management services These devices are used to non-invasively diagnosis and...

Australian health care sector is one of the fastest growing, dynamic and highly diversified sectors having enormous potential to generate substantial returns for the Australian economy. A broad range of companies, from companies engaged in...

Technology certainly plays a significant role in each segment of the industry, more so than ever, and health care sector is no different. Introduction of technologies in the health care domain emerged as the biggest blessing not only for pa...

CardieX Ltd (ASX:CDX) has entered into a JV with the largest Google wearable platform partner in China. This extremely promising news regarding the co-development of its consumer wearable applications saw its shares surge 40% when it recomm...

Shares in CardieX (ASX:CDX) have spiked 54 per cent this morning to 3.7c, their highest point since May, on a deal with private Chinese consumer electronics maker Mobvoi. CardieX, which is helmed by serial entrepreneur Craig Cooper and is k...

Digital health technology company CardieX (ASX: CDX) has struck a multi-year deal with Mobvoi Information Technology – currently Google’s official operating partner in China – for the development of smart-wearable solutions for Google’s Wea...

Rewardle Holdings Limited Social media company Rewardle Holdings Limited (ASX: RXH) connects more than 3.2 million members with nearly 5,000 local businesses across Australia. Strategic Partnership with Pepper Leaf Meal Kit Delivery Servic...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...